To test this hypothesis, we treated sorl1 F0 knockouts and controls with citalopram, a selective serotonin reuptake inhibitor (SSRI) used to treat depression (Andersen et al., 2009). This evidence concerns the gene SORL1 and depressive symptom measurement.